BeOne Medicines
ONC
#670
Rank
$39.30 B
Marketcap
$347.48
Share price
-2.40%
Change (1 day)
8.13%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Financial Statements

Thumbnail BeOne Medicines Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement